Treosulfan-based Conditioning
Treosulfan-Based Conditioning is a reduced-intensity conditioning regimen in hematopoietic stem cell transplantation that utilizes treosulfan, an alkylating agent, as the cornerstone cytotoxic component to enable engraftment with reduced organ toxicity compared to traditional myeloablative protocols.
99
Publications
4.5K
Citations
795
Authors
306
Institutions
Publications per year
2017–2026
45
99
Dietrich W. Beelen, Rudolf Trenschel, Matthias Stelljes et al. · The Lancet Haematology · 2019 · 154 citations · Full text
Medicine, Hematology, Immunology +17
Nicoletta Cieri, Raffaella Greco, Lara Crucitti et al. · Biology of Blood and Marrow Transplantation · 2015 · 140 citations · Full text
Medicine, Hematology, Immunology +16
1–5 of 99
795
13
h-index
13
h-index
9
h-index
9
h-index
8
h-index
1–5 of 795
306
University Medical Center Hamburg-Eppendorf
Hamburg, Germany
13 h-index
56 publications
3.5K citations
Universität Hamburg
Hamburg, Germany
13 h-index
56 publications
3.5K citations

Sheba Medical Center
Ramat Gan, Israel
12 h-index
39 publications
1.5K citations
Medac (Germany)
Wedel, Germany
12 h-index
30 publications
2.1K citations
Essen University Hospital
Essen, Germany
11 h-index
24 publications
964 citations
Medizinische Hochschule Hannover
Hanover, Germany
11 h-index
13 publications
789 citations
University College London
London, United Kingdom
11 h-index
36 publications
2.9K citations
Istituti di Ricovero e Cura a Carattere Scientifico
Rome, Italy
11 h-index
72 publications
4K citations
1–8 of 306
20 publications · 831 citations
15
h-index
TCT · 13 publications · 806 citations
13
h-index
BJH · 7 publications · 336 citations
7
h-index
6 publications · 224 citations
6
h-index
4 publications · 151 citations
4
h-index
1–5